Market Tracker

07/29 6:05pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

6.43
Data as of Jul 29
 +0.14 / +2.23%
Today’s Change
3.93
Today|||52-Week Range
8.22
+13.01%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close6.29
Today’s open6.31
Day’s range6.30 - 6.49
Volume14,577
Average volume (3 months)23,859
Market cap$201.3M
Dividend yield--
Data as of 3:59pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales4.82
Price/Book5.39

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.20+2.27%
OXFDOxford Immunotec Glo...-0.06-0.38%
CGIXCancer Genetics Inc-0.42-3.78%
ERBERBA Diagnostics Inc-0.04-1.89%
Data as of 4:00pm ET, 07/29/2014

Financials

Next reporting dateSeptember 29, 2014
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$17.9M
Annual profit (last year)$23.2K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts